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Introduction
TGFb contributes to Th17 and Treg development and
has pro and anti-inflammatory properties. However, its
role in rheumatoid arthritis is controversial. p17 is a
short synthetic peptide that selectively inhibits TGFb.
Aim
To analyse the effect of TGFb blockade with p17 in the
murine model of collagen-induced arthritis (CIA), during
induction of arthritis or clinical progression of the disease.
Methods
Male DBA/1 mice were immunized intradermally with
type-II collagen (CII) in Complete Freund’s Adjuvant. To
analyse the contribution of TGFb to the induction of
CIA, mice were treated daily with p17 or vehicle (PBS)
during 3 weeks starting at the time of immunization. The
role of TGFb in progression of established arthritis was
assessed by treating daily for 10 days starting on the day
of arthritis onset. Signs of arthritis were monitored
according to clinical and inflammation scales. Histologi-
cal damage was analysed by hematoxylin-eosin and safra-
nin staining. T cell population frequency was analysed by
flow cytometry in lymph node cell suspensions. mRNA
levels were analysed by RT-qPCR. The response to CII
was quantified with WST-1. IL6 and anti-CII-Ab were
quantified by ELISA. Statistical differences between
groups were compared using Student’s t-test or Mann-
Whitney U as required.
Results
In the induction phase, p17 reduced arthritis severity,
number of affected joints, histological joint inflammation
and cartilage damage, but differences were not statistically
significant (area under curve of clinical score change:
PBS=48.24±8.34, p17=30.57±6.35; p=0,09). Blockade of
TGFb did not modify the frequency of Th1, Th2 and
Th17 cells, but significantly reduced the percentage of
Treg cells (PBS=7.79±0.17, p17=6.39±0.57; p=0,03). Levels
of IL6, IL17, IFNg and Foxp3 mRNA were comparable in
spleen and joints. There were no significant differences in
specific proliferation to CII or the production of IL6 and
anti-CII-Ab IgG1/IgG2a. In the phase of established dis-
ease, p17 reduced the severity of arthritis although this dif-
ference was not statistically significant (PBS=29.04±5.28,
p17=20.72±4.18; p=0,22). Finally, the blockade of TGFb
did not affect other parameters analyzed.
Conclusion
Treatment of CIA with p17 does not have a statistically
significant effect on the course of arthritis, suggesting
that TGFb plays a minor role in this pathology.
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